Literature DB >> 3378212

Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D.

J F Glover1, J T Irwin, P D Darbre.   

Abstract

Studies reported here confirm that the pH indicator, phenol red, acts as a weak estrogen and reexamine the significance of estrogenic and antiestrogenic effects on growth of the human breast cancer cell lines ZR-75-1 and T-47-D in the absence of phenol red. Removal of phenol red reduces but does not immediately eliminate cell growth in the absence of estradiol. Basal cell growth can be reduced for T-47-D cells and eliminated for ZR-75-1 cells by prior growth in the absence of steroid and phenol red for 3 weeks, demonstrating that estrogens can have long lasting effects on cells in culture (termed "steroid memory") and that there exist both cells which are responsive (T-47-D) and dependent (ZR-75-1) on estradiol for growth. Antiestrogen action in these cell lines is affected by at least four parameters: (a) presence of phenol red; (b) time in culture; (c) cell density; (d) steroid memory effects. At high cell density, antiestrogens suppress phenol red-stimulated activity but have little effect in the absence of phenol red. However, at low cell density in the absence of phenol red, tamoxifen has a biphasic action: initial weak stimulation, later inhibition. trans-Hydroxytamoxifen does not stimulate but inhibition increases with time in culture. Following deprivation for 3 weeks of phenol red and steroid, antiestrogen action on ZR-75-1 cells at low density became much more inhibitory. Such responses to antiestrogens are discussed in relation to possible autocrine/paracrine growth regulation of the cells. Clinical relevance is suggested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3378212

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Estrogen mitogenic action. III. is phenol red a "red herring"?

Authors:  J E Moreno-Cuevas; D A Sirbasku
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Jul-Aug       Impact factor: 2.416

2.  Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.

Authors:  K Abdul-Wahab; D Corcoran; A Perachiotti; P D Darbre
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

Review 3.  Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses.

Authors:  J A Da Silva
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

4.  Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status.

Authors:  K Nesaretnam; R Stephen; R Dils; P Darbre
Journal:  Lipids       Date:  1998-05       Impact factor: 1.880

5.  Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.

Authors:  C K Watts; K J Sweeney; A Warlters; E A Musgrove; R L Sutherland
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Downregulation of RhoGDIα increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells.

Authors:  Somayeh Hooshmand; Abbas Ghaderi; Khatijah Yusoff; Thilakavathy Karrupiah; Rozita Rosli; Zahra Mojtahedi
Journal:  Cell Adh Migr       Date:  2013-04-05       Impact factor: 3.405

7.  Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.

Authors:  D E Haagensen; P Stewart; W G Dilley; S A Wells
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum.

Authors:  W V Welshons; L H Grady; K S Engler; B M Judy
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Moderate levels of glyphosate and its formulations vary in their cytotoxicity and genotoxicity in a whole blood model and in human cell lines with different estrogen receptor status.

Authors:  L K S De Almeida; B I Pletschke; C L Frost
Journal:  3 Biotech       Date:  2018-10-04       Impact factor: 2.406

10.  Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype.

Authors:  H W van den Berg; M Lynch; J Martin; J Nelson; G R Dickson; A D Crockard
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.